Clinical Trials Browser

Carcinoma, Neuroendocrine × Temozolomide × 90 days × Clear all

NCT02595424 2026-05-01

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Phase 2 Active not recruiting

67 enrolled 13 charts

Somatostatinoma, Carcinoma, Neuroendocrine